Targeted social marketing of PrEP and the stigmatization of black sexual minority men
Sarah K. Calabrese(Yale University), María Cecilia Zea(George Washington University), John F. Dovidio(University of Connecticut), Sharanya Rao(George Washington University), Djordje Modrakovic(George Washington University), Manya Magnus(Milken Institute), Michael Kharfen(Government of the District of Columbia), David A. Kalwicz(George Washington University), Cheriko A. Boone(George Washington University), Viraj V. Patel(Albert Einstein College of Medicine)
Cited by 25
Related Papers
Understanding Structural Barriers to Accessing HIV Testing and Prevention Services Among Black Men Who Have Sex with Men (BMSM) in the United States
|AIDS and Behavior|2014|303
Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061
|PLoS ONE|2013|196
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|177
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
|PLoS Medicine|2018|173
Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2007|169